160 related articles for article (PubMed ID: 34861474)
1. Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents.
Wang A; Xu S; Chai Y; Xia G; Wang B; Lv K; Wang D; Qin X; Jiang B; Wu W; Liu M; Lu Y
Bioorg Med Chem; 2022 Jan; 53():116529. PubMed ID: 34861474
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of nitrofuranyl methyl N-heterocycles derivatives as novel antitubercular agents.
Wang A; Li W; Wang B; Lv K; Wang H; Liu M; Guo H; Lu Y
Future Med Chem; 2018 Sep; 10(17):2059-2068. PubMed ID: 29992836
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of (E)-5-styryl-1,2,4-oxadiazoles as anti-tubercular agents.
Atmaram Upare A; Gadekar PK; Sivaramakrishnan H; Naik N; Khedkar VM; Sarkar D; Choudhari A; Mohana Roopan S
Bioorg Chem; 2019 May; 86():507-512. PubMed ID: 30776681
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, antituberculosis studies and biological evaluation of new quinoline derivatives carrying 1,2,4-oxadiazole moiety.
Shruthi TG; Eswaran S; Shivarudraiah P; Narayanan S; Subramanian S
Bioorg Med Chem Lett; 2019 Jan; 29(1):97-102. PubMed ID: 30448235
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and in vitro antituberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,3,4-oxadiazole derivatives.
Sajja Y; Vanguru S; Vulupala HR; Nagarapu L; Perumal Y; Sriram D; Nanubolu JB
Chem Biol Drug Des; 2017 Oct; 90(4):496-500. PubMed ID: 28267891
[TBL] [Abstract][Full Text] [Related]
6.
Deb PK; Al-Shar'i NA; Venugopala KN; Pillay M; Borah P
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):869-884. PubMed ID: 34060396
[TBL] [Abstract][Full Text] [Related]
7. Conjugation of a 5-nitrofuran-2-oyl moiety to aminoalkylimidazoles produces non-toxic nitrofurans that are efficacious in vitro and in vivo against multidrug-resistant Mycobacterium tuberculosis.
Krasavin M; Lukin A; Vedekhina T; Manicheva O; Dogonadze M; Vinogradova T; Zabolotnykh N; Rogacheva E; Kraeva L; Yablonsky P
Eur J Med Chem; 2018 Sep; 157():1115-1126. PubMed ID: 30179748
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of alkynylated 1,2,4-oxadiazole/1,2,3-1H-triazole glycoconjugates: Discovering new compounds for use in chemotherapy against lung carcinoma and Mycobacterium tuberculosis.
Melo de Oliveira VN; Flávia do Amaral Moura C; Peixoto ADS; Gonçalves Ferreira VP; Araújo HM; Lapa Montenegro Pimentel LM; Pessoa CDÓ; Nicolete R; Versiani Dos Anjos J; Sharma PP; Rathi B; Pena LJ; Rollin P; Tatibouët A; Nascimento de Oliveira R
Eur J Med Chem; 2021 Aug; 220():113472. PubMed ID: 33940463
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel class of quinoline-oxadiazole hybrids as anti-tuberculosis agents.
Jain PP; Degani MS; Raju A; Anantram A; Seervi M; Sathaye S; Ray M; Rajan MGR
Bioorg Med Chem Lett; 2016 Jan; 26(2):645-649. PubMed ID: 26675440
[TBL] [Abstract][Full Text] [Related]
10. Optimization of N-benzyl-5-nitrofuran-2-carboxamide as an antitubercular agent.
Gallardo-Macias R; Kumar P; Jaskowski M; Richmann T; Shrestha R; Russo R; Singleton E; Zimmerman MD; Ho HP; Dartois V; Connell N; Alland D; Freundlich JS
Bioorg Med Chem Lett; 2019 Feb; 29(4):601-606. PubMed ID: 30600207
[TBL] [Abstract][Full Text] [Related]
11. Current development of 5-nitrofuran-2-yl derivatives as antitubercular agents.
Elsaman T; Mohamed MS; Mohamed MA
Bioorg Chem; 2019 Jul; 88():102969. PubMed ID: 31077910
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
Desai NC; Somani H; Trivedi A; Bhatt K; Nawale L; Khedkar VM; Jha PC; Sarkar D
Bioorg Med Chem Lett; 2016 Apr; 26(7):1776-83. PubMed ID: 26920799
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of oxime-functionalized nitrofuranylamides as novel antitubercular agents.
Fan YL; Wu JB; Ke X; Huang ZP
Bioorg Med Chem Lett; 2018 Oct; 28(18):3064-3066. PubMed ID: 30119957
[TBL] [Abstract][Full Text] [Related]
14. Development of water-soluble 3,5-dinitrophenyl tetrazole and oxadiazole antitubercular agents.
Roh J; Karabanovich G; Vlčková H; Carazo A; Němeček J; Sychra P; Valášková L; Pavliš O; Stolaříková J; Klimešová V; Vávrová K; Pávek P; Hrabálek A
Bioorg Med Chem; 2017 Oct; 25(20):5468-5476. PubMed ID: 28835350
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents.
Suresh Kumar GV; Rajendraprasad Y; Mallikarjuna BP; Chandrashekar SM; Kistayya C
Eur J Med Chem; 2010 May; 45(5):2063-74. PubMed ID: 20149496
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis.
Fernandes GFDS; de Souza PC; Marino LB; Chegaev K; Guglielmo S; Lazzarato L; Fruttero R; Chung MC; Pavan FR; Dos Santos JL
Eur J Med Chem; 2016 Nov; 123():523-531. PubMed ID: 27508879
[TBL] [Abstract][Full Text] [Related]
17. Oxadiazole scaffolds in anti-tuberculosis drug discovery.
De SS; Khambete MP; Degani MS
Bioorg Med Chem Lett; 2019 Aug; 29(16):1999-2007. PubMed ID: 31296357
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel 5-aryl-2-thio-1,3,4-oxadiazoles and the study of their structure-anti-mycobacterial activities.
Macaev F; Rusu G; Pogrebnoi S; Gudima A; Stingaci E; Vlad L; Shvets N; Kandemirli F; Dimoglo A; Reynolds R
Bioorg Med Chem; 2005 Aug; 13(16):4842-50. PubMed ID: 15993090
[TBL] [Abstract][Full Text] [Related]
19. Attachment of a 5-nitrofuroyl moiety to spirocyclic piperidines produces non-toxic nitrofurans that are efficacious in vitro against multidrug-resistant Mycobacterium tuberculosis.
Krasavin M; Lukin A; Vedekhina T; Manicheva O; Dogonadze M; Vinogradova T; Zabolotnykh N; Rogacheva E; Kraeva L; Sharoyko V; Tennikova TB; Dar'in D; Sokolovich E
Eur J Med Chem; 2019 Mar; 166():125-135. PubMed ID: 30703656
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel 2-aminothiazole conjugated nitrofuran as antitubercular and antibacterial agents.
Ran K; Gao C; Deng H; Lei Q; You X; Wang N; Shi Y; Liu Z; Wei W; Peng C; Xiong L; Xiao K; Yu L
Bioorg Med Chem Lett; 2016 Aug; 26(15):3669-74. PubMed ID: 27289321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]